Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Garden State Infectious Disease Associates (GSIDA) is a specialized medical practice based in Southern New Jersey that provides comprehensive care for patients with complex infectious diseases. The group offers a range of services including inpatient and outpatient consultations, travel medicine, and long-term intravenous antibiotic therapy through their infusion centers. In addition to clinical practice, GSIDA serves as a clinical research site, participating in Phase 2 through Phase 4 clinical trials for pharmaceutical companies developing new anti-infective agents and vaccines. Their expertise covers a broad spectrum of conditions, including HIV/AIDS management, chronic hepatitis, and emerging infectious threats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Garden State Infectious Disease Associates.